Clinical Trials Logo

Filter by:
NCT ID: NCT00350948 Terminated - Ovarian Neoplasms Clinical Trials

Phase 3 Randomized Study of Telcyta + Doxorubicin Versus Doxorubicin in Platinum Refractory or Resistant Ovarian Cancer

ASSIST-5
Start date: May 2006
Phase: Phase 3
Study type: Interventional

The purpose of this research study is to determine if Telcyta® given in combination with liposomal doxorubicin is more effective than liposomal doxorubicin alone in treating women who have recurrent ovarian epithelial cancer, fallopian tube cancer or primary peritoneal cancer that is refractory or resistant to platinum chemotherapy.

NCT ID: NCT00350766 Terminated - Clinical trials for Acute Myocardial Infarction

Cell Therapy in Myocardial Infarction

EMRTCC
Start date: July 1, 2006
Phase: Phase 2/Phase 3
Study type: Interventional

The purpose of this study is to determine cell therapy efficacy in patients with ST elevation acute myocardial infarction (STEMI)

NCT ID: NCT00349271 Terminated - Clinical trials for Chagas Cardiomyopathy

Cell Therapy in Chagas Cardiomyopathy

Start date: January 2006
Phase: Phase 3
Study type: Interventional

The purpose of this study is to determine effect of cell therapy in patients with severe dilated cardiomyopathy

NCT ID: NCT00332826 Terminated - Asthma Clinical Trials

Inhaled Technosphere Insulin in Subjects With Diabetes Mellitus and Asthma

Start date: June 2006
Phase: Phase 3
Study type: Interventional

The clinical trial is designed to evaluate the safety of inhaled Technosphere/Insulin compared with non-inhaled anti-diabetic therapies in subjects with type 1 or type 2 diabetes mellitus and concurrent asthma.

NCT ID: NCT00331604 Terminated - Clinical trials for Diabetes Mellitus, Type 2

Safety and Efficacy of Inhaled Insulin in Type 2 Diabetes

Start date: August 31, 2006
Phase: Phase 3
Study type: Interventional

This trial is conducted in Asia, Europe and South America. The aim of this research is to compare the efficacy (reduction in HbA1c and blood glucose) and pulmonary safety (pulmonary function tests, chest x-rays) of mealtime inhaled insulin with subcutaneous insulin aspart both in combination with insulin detemir in Type 2 Diabetes.

NCT ID: NCT00322543 Terminated - Coronary Disease Clinical Trials

Reduced Anti-Platelet Therapy With Pimecrolimus Drug Eluting Stent (RAPID)

Start date: May 2006
Phase: Phase 3
Study type: Interventional

Non-randomized, single arm, multi-center, clinical trial evaluating the Corio™ pimecrolimus-eluting stent with reduced anti-platelet therapy in patients with de novo lesions of the native coronary arteries.

NCT ID: NCT00315003 Terminated - Clinical trials for Otitis Media, Suppurative

TELI COM - Telithromycin in Children With Otitis Media

Start date: January 2006
Phase: Phase 3
Study type: Interventional

This is a multinational, randomized (1:1), double-blind, double-dummy, comparative, 2- treatmentgroup study in children (age range: ≥6 months and <72 months [< 6 years of age]) with AOM.Subjects will be randomized to receive either telithromycin (50 mg/mL) oral suspension 25 mg/kgonce daily for 5 days or azithromycin (40 mg/mL) oral suspension (10 mg/kg once on Day 1, followed by 5 mg/kg once daily on Days 2-5, not to exceed 500 mg onDay 1 and 250 mg/day from Days 2 - 5. Matching placebo suspensions for telithromycin and azithromycin will also be dispensed to provide blinding for the different treatment regimens.Assessments and reporting of safety will be carried out at all visits.

NCT ID: NCT00303082 Terminated - Sepsis Clinical Trials

Probiotics for the Prevention of Premature Birth and Neonatal Related Morbidity

Start date: January 2006
Phase: Phase 3
Study type: Interventional

The trial intends to evaluate the efficacy of specially designed probiotics to prevent premature birth and related neonatal morbidity associated to intra-uterine infection. The tested probiotics are efficacious to decrease the prevalence of bacterial vaginosis. The study hypothesis is that the early administration of those probiotics to pregnant women with bacterial vaginosis can prevent premature birth through antibiotic activity and modulation of the immune response to infection.

NCT ID: NCT00300885 Terminated - Clinical trials for Carcinoma, Non-Small Cell Lung

A Randomized Controlled Trial Comparing Safety and Efficacy of Carboplatin and Paclitaxel Plus or Minus Sorafenib (BAY 43-9006) in Chemonaive Patients With Stage IIIB-IV Non-Small Cell Lung Cancer (NSCLC)

Start date: February 2006
Phase: Phase 3
Study type: Interventional

A randomized controlled trial comparing safety and efficacy of carboplatin and paclitaxel plus or minus sorafenib in chemonaive patients with stage III-IV non-small cell lung cancer.

NCT ID: NCT00295165 Terminated - Crohn Disease Clinical Trials

Efficacy (Induction of Response/Remission) and Safety Study in Patients With Moderate to Severe Crohn's Disease

Start date: January 2006
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate if Leukine can induce clinical response or remission in patients with Crohn's disease.